UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000046416 |
|---|---|
| Receipt number | R000052961 |
| Scientific Title | Examination of the effects of a test food on salivary IgA and gut microbiota |
| Date of disclosure of the study information | 2021/12/20 |
| Last modified on | 2022/06/21 09:19:36 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Examination of the effects of a test food on salivary IgA and gut microbiota
Acronym
Examination of the effects of a test food on immune function
Scientific Title
Examination of the effects of a test food on salivary IgA and gut microbiota
Scientific Title:Acronym
Examination of the effects of a test food on immune function
Region
| Japan |
Condition
Condition
Healthy Adults
Classification by specialty
| Not applicable |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
This study aims to examine the effects of a test food on salivary IgA and gut microbiota.
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Amount of salivary IgA(1)
(1)0 and 4 weeks after the starts of intake
Key secondary outcomes
[1] Gut microbiota analysis(1)
[2] Questionnaire on defecation status(2)
[3] Questionnaire on cold symptoms(1)
(1)0 and 4 weeks after the starts of intake
(2)Daily 2 weeks before and 4 weeks during intake
Base
Study type
Interventional
Study design
Basic design
Single arm
Randomization
Non-randomized
Randomization unit
Blinding
Open -no one is blinded
Control
Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
1
Purpose of intervention
Prevention
Type of intervention
| Food |
Interventions/Control_1
Ingest a test food daily for 4 weeks
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| 64 | years-old | >= |
Gender
Male and Female
Key inclusion criteria
[1] Persons who received a sufficient explanation of the purpose and contents of the exam, have the capacity to consent, applied with free will with sufficient understanding, and agreed to participate with a written document
[2] Healthy Japanese who are 20 years old or more and under 65 years old
[3] Persons who are aware of constipation tendency (defecate 2 to 5 times / week)
Key exclusion criteria
[1] Persons who have chronic illness, receiving medication, have a serious disease history
[2] Persons who are allergic to barley, wheat or rye
[3] Persons who usually take a large amount of this test food
[4] Persons who usually use pharmaceutical products and foods with health claims that may affect the intestinal environment and immunity
[5] Persons who have participated in other studies within the first month before the start of this study, or persons who intend to participate in another study after consenting to this study
[6] Persons who are pregnant, planning or hoping to be pregnant during the study period, breastfeeding
[7] Persons who were judged as inappropriate for study participants by the principal investigator
Target sample size
30
Research contact person
Name of lead principal investigator
| 1st name | Yuki |
| Middle name | |
| Last name | Asahina |
Organization
Healthcare Systems Co., Ltd.
Division name
Research and Development Department
Zip code
105-0004
Address
Nisshin Tatemono Shinbashi Bld. 7F, 4-6-15 Shinbashi, Minato-ku, Tokyo, JAPAN
TEL
03-6809-2722
asahina.yuki@hc-sys.jp
Public contact
Name of contact person
| 1st name | Yuki |
| Middle name | |
| Last name | Asahina |
Organization
Healthcare Systems Co., Ltd.
Division name
Research and Development Department
Zip code
105-0004
Address
Nisshin Tatemono Shinbashi Bld. 7F, 4-6-15 Shinbashi, Minato-ku, Tokyo, JAPAN
TEL
03-6809-2722
Homepage URL
asahina.yuki@hc-sys.jp
Sponsor or person
Institute
Healthcare Systems Co., Ltd.
Institute
Department
Personal name
Funding Source
Organization
TEIJIN LIMITED
Organization
Division
Category of Funding Organization
Profit organization
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
The Ethics Committee of Healthcare Systems Co., Ltd.
Address
Nisshin Tatemono Shinbashi Bld. 7F, 4-6-15 Shinbashi, Minato-ku, Tokyo, JAPAN
Tel
03-6809-2722
soumu@hc-sys.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2021 | Year | 12 | Month | 20 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
29
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2021 | Year | 12 | Month | 17 | Day |
Date of IRB
| 2021 | Year | 12 | Month | 17 | Day |
Anticipated trial start date
| 2022 | Year | 01 | Month | 08 | Day |
Last follow-up date
| 2022 | Year | 02 | Month | 19 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2021 | Year | 12 | Month | 20 | Day |
Last modified on
| 2022 | Year | 06 | Month | 21 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000052961
